Citius Pharmaceuticals, Inc. Logo

Citius Pharmaceuticals, Inc.

A late-stage biopharmaceutical company developing and commercializing critical care products.

CTXR | US

Overview

Corporate Details

ISIN(s):
US17322U2078
LEI:
Country:
United States of America
Address:
11 COMMERCE DRIVE, 7016 CRANFORD

Description

Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company that develops and commercializes critical care products. The company's diversified pipeline focuses on anti-infectives in adjunct cancer care, stem cell therapies, and prescription products. Its portfolio includes LYMPHIR™, an FDA-approved therapy for adult patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL). Key product candidates in development include Mino-Lok®, an antibiotic lock solution intended to treat patients with catheter-related bloodstream infections, and Halo-Lido, a topical formulation for the treatment of hemorrhoids. Additionally, the company is advancing a stem cell therapy platform for conditions such as acute respiratory distress syndrome (ARDS).

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2023-02-07 17:05
CURRENT REPORT
English ZIP 78.9 KB
2022-12-22 17:40
CURRENT REPORT
English ZIP 147.9 KB
2022-12-22 17:37
DEFINITIVE ADDITIONAL MATERIALS
English ZIP 547.1 KB
2022-12-22 17:35
DEFINITIVE PROXY STATEMENT
English ZIP 1.1 MB
2022-12-22 17:30
ANNUAL REPORT
English ZIP 1.3 MB
2022-12-01 17:15
CURRENT REPORT
English ZIP 116.0 KB
2022-11-21 10:15
CURRENT REPORT
English ZIP 101.7 KB
2022-11-15 17:05 English ZIP 6.9 KB
2022-10-06 18:10 English ZIP 8.1 KB
2022-10-06 18:09 English ZIP 8.3 KB
2022-10-06 18:08 English ZIP 9.2 KB
2022-10-06 18:08 English ZIP 9.0 KB
2022-10-06 18:07 English ZIP 8.3 KB
2022-10-06 18:07 English ZIP 8.1 KB
2022-10-06 18:06 English ZIP 8.1 KB

Automate Your Workflow. Get a real-time feed of all Citius Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Citius Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Citius Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Arcus Biosciences, Inc. Logo
A clinical-stage biopharmaceutical company developing combination therapies for cancer.
United States of America
RCUS
Arcutis Biotherapeutics, Inc. Logo
Develops and commercializes treatments for immune-mediated skin diseases.
United States of America
ARQT
ARDELYX, INC. Logo
Biopharmaceutical company developing medicines for cardiorenal and gastrointestinal diseases.
United States of America
ARDX
ARECOR THERAPEUTICS PLC Logo
Biopharmaceutical company enhancing medicines with its proprietary formulation technology.
United Kingdom
AREC
argenx SE Logo
Develops and commercializes antibody-based therapies for severe autoimmune diseases.
Netherlands
1AE
Armata Pharmaceuticals, Inc. Logo
Develops bacteriophage therapeutics for antibiotic-resistant bacterial infections.
United States of America
ARMP
AroCell AB Logo
Develops and markets in vitro diagnostic (IVD) tests for oncology and bacteriology.
Sweden
AROC
ArriVent BioPharma, Inc. Logo
Clinical-stage biopharma developing oncology drugs for difficult-to-treat diseases.
United States of America
AVBP
ARROWHEAD PHARMACEUTICALS, INC. Logo
Biotechnology company developing RNAi therapies to treat intractable diseases.
United States of America
ARWR
ARS Pharmaceuticals, Inc. Logo
Develops and commercializes needle-free products for administering therapies.
United States of America
SPRY

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.